U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Favezelimab
H1396W7D1H
Investigational
General
Names
10
Classification
1
Identifiers
6
Subunits
4
Related Substances
1
Favezelimab
H1396W7D1H
Investigational
General
Approval Year
Unknown
149,124
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
MK-4280
Preferred Name
English
Favezelimab
Official Name
English
MK4280
Code
English
Favezelimab [WHO-DD]
Common Name
English
MAVEZELIMAB
Common Name
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Monoclonal Antibody
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
[C20401]
Anti-LAG-3 Monoclonal Antibody
NCI_THESAURUS
C134305
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
INN
11179
PRIMARY
FDA UNII
H1396W7D1H
PRIMARY
USAN
KL-177
PRIMARY
SMS_ID
300000008665
PRIMARY
NCI_THESAURUS
C142077
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
H1396W7D1H
Favezelimab